CAS |
483367-10-8 |
English Name |
Purmorphamine |
Synonyms |
9H-Purin-6-amine |
Molecular Formula |
C31H32N6O2 |
Molecular Weight |
520.62 |
Solubility |
Soluble in DMSO |
Purity |
≥97% |
Appearance |
White to off-white Solid |
Storage |
Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
Delivery Time |
1-2 Days |
EC |
EINECS 200-256-5 |
MDL |
MFCD09037557 |
SMILES |
N1(C2=CC=C(NC3=NC(OC4=CC=CC5=C4C=CC=C5)=NC6=C3N=CN6C7CCCCC7)C=C2)CCOCC1 |
InChIKey |
FYBHCRQFSFYWPY-UHFFFAOYSA-N |
InChI |
InChI=1S/C31H32N6O2/c1-2-9-25(10-3-1)37-21-32-28-29(33-23-13-15-24(16-14-23)36-17-19-38-20-18-36)34-31(35-30(28)37)39-27-12-6-8-22-7-4-5-11-26(22)27/h4-8,11-16,21,25H,1-3,9-10,17-20H2,(H,33,34,35) |
PubChem CID |
5284329 |
Target Point |
Hedgehog/Smoothened agonist |
Passage |
Hedgehog;Stem Cells |
Background |
Purmorphamine is a smooth receptor agonist. |
Biological Activity |
Purmorphamine是一种平滑受体激动剂,EC50为1 μM。[1-3] |
IC50 |
1.5μM(Smoothened) |
In Vitro |
根据MTT测定,Purmorphamine(10,20μM)与西罗莫司组合显著降低细胞数量。在第14天,Purmorphamine诱导碱性磷酸酶活性和RUNX-2表达的上调。诱导后第14天在3和5μM剂量的嘌呤胺上检测到骨钙蛋白的上调。在存在或不存在嘌吗啡胺的情况下,基质矿化保持不变[1]。 Purmorphamine诱导小鼠ES细胞系ES14和间充质干细胞系C3H10T1/2中的STAT3磷酸化[2]。 Purmorphamine上调人骨髓间充质细胞中成骨细胞表型-ALP活性和骨样结节形成标志物的表达[3]。 |
Cell Experiment |
为了确定小分子的无毒剂量,将5×105个传代-3的人MSC接种在六孔培养板的每个孔中,并在37℃,5%CO 2下在扩增培养基(如上所述)中温育。两天后,将培养基更换为成骨培养基(OM),其由补充有10%FBS,10nM地塞米松,50μg/ mL抗坏血酸2-磷酸和10mMβ-甘油磷酸的α-MEM组成。该OM补充有不同浓度的嘌吗啡胺(1,3,5,10和20μM)和西罗莫司(0.1,1,10,100和200nM)。将培养物再保持2天,然后通过MTT测定,通过以1:5的比例向培养基中加入MTT溶液(PBS中5mg/mL)评估活细胞的存在。然后将细胞在37℃和5%CO 2下孵育。两小时后,除去培养基并向处理过的细胞中加入500μLDMSO以溶解形成区沉淀。在570nm处读取光学吸收率。细胞活力计算为相对于仅用OM处理的对照组的百分比值。 |
Data Literature Source |
[1]. F. Faghihia,et al. The effect of purmorphamine and sirolimus on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Biomedicine & Pharmacotherapy. 2013,67(1): 31-38. [2]. Gu D,et al. A role for transcription factor STAT3 signaling in oncogene smoothened-driven carcinogenesis. J Biol Chem. 2012 Nov 2;287(45):38356-66. [3]. Beloti MM,et al. Purmorphamine enhances osteogenic activity of human osteoblasts derived from bone marrow mesenchymal cells. Cell Biol Int. 2005 Jul;29(7):537-41. |
Unit |
Piece |
Specification |
5mg 10mg 20mg |